Acute Coronary Syndromes, Third Edition
Eric J. Topol
CRC Press, Nov 8, 2000 - Medical - 880 pages
Reflecting rapid innovations in the field, Acute Coronary Syndromes, Second Edition uncovers the structural, physiological, and functional foundations of acute coronary syndromes-including the latest advances in the causes of inflammation and embolization, therapeutics, intravenous and oral antiplatelet agents, and anticoagulants.
Presents original theories in the cost-effectiveness of diagnostic therapies of acute coronary syndromes!
Providing seven new chapters demonstrating the most up-to-date information on invasive and conservative management strategies, aspirin resistance, and public health implications, Acute Coronary Syndromes, Second Edition
Written by over 40 international experts in the field, Acute Coronary Syndromes, Second Edition is a monumental reference for cardiologists; internists; epidemiologists; molecular and cell biologists; pharmacologists; emergency room personnel; and graduate and medical school students in these disciplines.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Inflammation in Acute Coronary Syndromes
Vascular Biology of the Acute Coronary Syndromes
Pathological and Anatomical
Embolization as a Pathological Mechanism
Insights from Intravascular Ultrasound
Differences Between Unstable Angina and Acute
ThirdGeneration Thrombolytic Agents for Acute
Antithrombin Therapy in Acute Coronary Syndromes
Bedside Anticoagulant Testing
Bedside Platelet Monitoring
Hypolipidemic Intervention and Plaque Stabilization
Combination Fibrinolysis and Platelet IIbIIIa Antagonism
Diagnosis of Acute Coronary Syndromes in
The Role of the Troponins and Other Markers
Stenting in Acute Myocardial Infarction
Early Invasive Versus Early Conservative Strategies
Intravenous Glycoprotein IIbIIIa Receptor Inhibitor
abciximab acute coronary syndromes acute myocardial infarction alteplase angiographic anticoagulation antiplatelet aPTT aspirin atherosclerosis atherosclerotic plaques bleeding bolus Califf RM cardiac cardiovascular chest pain cholesterol Circulation CK-MB Clin clinical clopidogrel collagen compared coronary angioplasty coronary artery disease costs creatine cTnT death diagnosis dose drug early effects elevation embolization endothelial endpoint Engl evaluation factors fibrinolytic flow function GPIIb/IIIa GUSTO GUSTO-I Heart hemorrhage heparin hirudin hospital IIb/IIIa receptor increased inhibition inhibitor intravenous Investigators ischemia ischemic JAm Coll Cardiol Lancet left ventricular lesions markers mortality myocardial rupture NEngl outcomes patency patients treated patients with acute patients with unstable percutaneous perfusion placebo plasminogen activator platelet platelet aggregation platelet glycoprotein IIb/IIIa primary angioplasty randomized trial reduced reperfusion reteplase revascularization risk ST-segment stent strategy streptokinase t-PA thrombin thrombolysis thrombolytic therapy thrombosis thrombus ticlopidine tirofiban tissue treatment troponin ultrasound unstable angina vascular versus